Smith+Nephew announces findings from a newly published, first-of-its-kind comparative study of single-use negative pressure ...
MK-2206 and Standard Neoadjuvant Chemotherapy Improves Response in Patients With Human Epidermal Growth Factor Receptor 2–Positive and/or Hormone Receptor–Negative Breast Cancers in the I-SPY 2 Trial ...
Phase II study of the anti-TGF-β monoclonal antibody (mAb) NIS793 with and without the PD-1 inhibitor spartalizumab in combination with nab-paclitaxel/gemcitabine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback